LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 45 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,000 | -88.9% | 350 | -84.2% | 0.00% | – |
| Q1 2022 | $9,000 | -57.1% | 2,218 | -49.9% | 0.00% | – |
| Q4 2021 | $21,000 | +600.0% | 4,427 | +532.4% | 0.00% | – |
| Q3 2021 | $3,000 | -70.0% | 700 | -71.2% | 0.00% | – |
| Q2 2021 | $10,000 | -41.2% | 2,427 | -36.6% | 0.00% | – |
| Q1 2021 | $17,000 | -59.5% | 3,826 | -64.2% | 0.00% | – |
| Q4 2020 | $42,000 | -20.8% | 10,700 | -18.2% | 0.00% | – |
| Q3 2020 | $53,000 | -36.9% | 13,082 | -34.1% | 0.00% | – |
| Q2 2020 | $84,000 | -24.3% | 19,845 | -24.8% | 0.00% | – |
| Q1 2020 | $111,000 | -9.0% | 26,406 | -14.7% | 0.00% | – |
| Q4 2019 | $122,000 | +13.0% | 30,972 | +152.2% | 0.00% | – |
| Q3 2019 | $108,000 | +390.9% | 12,282 | +435.2% | 0.00% | – |
| Q2 2019 | $22,000 | 0.0% | 2,295 | -31.9% | 0.00% | – |
| Q1 2019 | $22,000 | -86.5% | 3,369 | -80.5% | 0.00% | – |
| Q4 2018 | $163,000 | -76.0% | 17,240 | -48.8% | 0.00% | – |
| Q3 2018 | $678,000 | +226.0% | 33,701 | +372.1% | 0.00% | – |
| Q2 2018 | $208,000 | -92.8% | 7,138 | -92.7% | 0.00% | -100.0% |
| Q1 2018 | $2,907,000 | +482.6% | 97,622 | +529.3% | 0.00% | – |
| Q4 2017 | $499,000 | -25.2% | 15,513 | -19.0% | 0.00% | – |
| Q3 2017 | $667,000 | -22.0% | 19,163 | -33.3% | 0.00% | – |
| Q2 2017 | $855,000 | +375.0% | 28,715 | +376.1% | 0.00% | – |
| Q1 2017 | $180,000 | +27.7% | 6,031 | -25.5% | 0.00% | – |
| Q4 2016 | $141,000 | -43.4% | 8,092 | -22.8% | 0.00% | – |
| Q3 2016 | $249,000 | +33.9% | 10,487 | -9.8% | 0.00% | – |
| Q2 2016 | $186,000 | -28.7% | 11,625 | -6.7% | 0.00% | – |
| Q1 2016 | $261,000 | -74.5% | 12,464 | -67.1% | 0.00% | -100.0% |
| Q4 2015 | $1,023,000 | +298.1% | 37,887 | +309.6% | 0.00% | – |
| Q3 2015 | $257,000 | -16.3% | 9,250 | -26.1% | 0.00% | – |
| Q2 2015 | $307,000 | +403.3% | 12,512 | +280.2% | 0.00% | – |
| Q1 2015 | $61,000 | -23.8% | 3,291 | -23.7% | 0.00% | – |
| Q4 2014 | $80,000 | – | 4,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 4,138,893 | $123,256,000 | 18.11% |
| Broadfin Capital, LLC | 1,656,720 | $49,337,000 | 7.69% |
| SECTORAL ASSET MANAGEMENT INC | 1,128,219 | $33,598,000 | 3.68% |
| Perceptive Advisors | 4,313,611 | $128,459,000 | 3.60% |
| RTW INVESTMENTS, LP | 1,122,540 | $33,429,000 | 3.18% |
| Asymmetry Capital Management, L.P. | 55,864 | $1,664,000 | 2.08% |
| EMORY UNIVERSITY | 77,335 | $2,303,000 | 1.64% |
| Monashee Investment Management LLC | 185,000 | $5,509,000 | 1.52% |
| SPHERA FUNDS MANAGEMENT LTD. | 260,000 | $7,743,000 | 1.18% |
| Stanley-Laman Group, Ltd. | 167,825 | $4,998,000 | 1.14% |